Gandaglia, GiorgioPellegrino, FrancescoGoloza, AsiehDe Meulder, BertrandAbbott, ThomasAchtman, ArielOmar, Muhammad ImranAlshammari, ThamirAreia, CarlosAsiimwe, AlexBeyer, KatharinaBjartell, AndersCampi, RiccardoCornford, PhilipFalconer, ThomasQin, FengGong, MengchunHerrera, RonaldHughes, NigelHulsen, TimKinnaird, AdamLai, Lana YHMaresca, GianlucaMottet, NicolasOja, MarekPrinsen, PeterReich, ChristianRemmers, SebastiaanRoobol, Monique JSakalis, Vasileios I.Seage, SarahSmith, Emma JaneSnijde, RobertSteinbeisser, CarlThurin, Nicolas H.Hijazy, Aymanvan Bochove, Keesvan den Bergh, Roderick C.N.Van Hemelrijck, MiekeWillemse, Peter-Paul M.Williamson, Mark AndrewKerman, Nazanin ZounematEvans-Axelson, SusanBriganti, AlbertoN'Dow, JamesPIONEER Consortium2024-04-172024-04-172024-05-01Gandaglia, G, Pellegrino, F, Goloza, A, De Meulder, B, Abbott, T, Achtman, A, Omar, M I, Alshammari, T, Areia, C, Asiimwe, A, Beyer, K, Bjartell, A, Campi, R, Cornford, P, Falconer, T, Qin, F, Gong, M, Herrera, R, Hughes, N, Hulsen, T, Kinnaird, A, Lai, L YH, Maresca, G, Mottet, N, Oja, M, Prinsen, P, Reich, C, Remmers, S, Roobol, M J, Sakalis, V I, Seage, S, Smith, E J, Snijde, R, Steinbeisser, C, Thurin, N H, Hijazy, A, van Bochove, K, van den Bergh, R C N, Van Hemelrijck, M, Willemse, P-P M, Williamson, M A, Kerman, N Z, Evans-Axelson, S, Briganti, A, N'Dow, J & PIONEER Consortium 2024, 'Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management : a PIONEER Analysis Based on Big Data', European Urology, vol. 85, no. 5, pp. 457-465. https://doi.org/10.1016/j.eururo.2023.06.0120302-2838ORCID: /0000-0002-1597-3126/work/138534470ORCID: /0000-0001-5340-0081/work/162725350https://hdl.handle.net/2164/23272Funding statement PIONEER is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 777492. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and European Federation of Pharmaceutical Industries and Associations EFPIA. The European Health Data & Evidence Network has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 806968. The Joint Undertaking is supported by the European Union’s Horizon 2020 research and innovation programme and EFPIA, a large association which represents the biopharmaceutical industry in Europe. The views communicated within are those of PIONEER. Neither the IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein91557748engSDG 3 - Good Health and Well-beingProstate cancerConservative managementSurvivalOutcomesBig DataPIONEERR MedicineEuropean Commission777492Other806968RJournal article10.1016/j.eururo.2023.06.012http://www.scopus.com/inward/record.url?scp=85164440972&partnerID=8YFLogxK855